Cargando…
Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020
BACKGROUND: The COVID-19 pandemic has led to an unprecedented daily use of RT-PCR tests. These tests are interpreted qualitatively for diagnosis, and the relevance of the test result intensity, i.e. the number of quantification cycles (Cq), is debated because of strong potential biases. AIM: We expl...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832522/ https://www.ncbi.nlm.nih.gov/pubmed/35144725 http://dx.doi.org/10.2807/1560-7917.ES.2022.27.6.2100406 |
_version_ | 1784648737230946304 |
---|---|
author | Alizon, Samuel Selinger, Christian Sofonea, Mircea T Haim-Boukobza, Stéphanie Giannoli, Jean-Marc Ninove, Laetitia Pillet, Sylvie Thibault, Vincent de Rougemont, Alexis Tumiotto, Camille Solis, Morgane Stephan, Robin Bressollette-Bodin, Céline Salmona, Maud L’Honneur, Anne-Sophie Behillil, Sylvie Lefeuvre, Caroline Dina, Julia Hantz, Sébastien Hartard, Cédric Veyer, David Delagrèverie, Héloïse M Fourati, Slim Visseaux, Benoît Henquell, Cécile Lina, Bruno Foulongne, Vincent Burrel, Sonia |
author_facet | Alizon, Samuel Selinger, Christian Sofonea, Mircea T Haim-Boukobza, Stéphanie Giannoli, Jean-Marc Ninove, Laetitia Pillet, Sylvie Thibault, Vincent de Rougemont, Alexis Tumiotto, Camille Solis, Morgane Stephan, Robin Bressollette-Bodin, Céline Salmona, Maud L’Honneur, Anne-Sophie Behillil, Sylvie Lefeuvre, Caroline Dina, Julia Hantz, Sébastien Hartard, Cédric Veyer, David Delagrèverie, Héloïse M Fourati, Slim Visseaux, Benoît Henquell, Cécile Lina, Bruno Foulongne, Vincent Burrel, Sonia |
author_sort | Alizon, Samuel |
collection | PubMed |
description | BACKGROUND: The COVID-19 pandemic has led to an unprecedented daily use of RT-PCR tests. These tests are interpreted qualitatively for diagnosis, and the relevance of the test result intensity, i.e. the number of quantification cycles (Cq), is debated because of strong potential biases. AIM: We explored the possibility to use Cq values from SARS-CoV-2 screening tests to better understand the spread of an epidemic and to better understand the biology of the infection. METHODS: We used linear regression models to analyse a large database of 793,479 Cq values from tests performed on more than 2 million samples between 21 January and 30 November 2020, i.e. the first two pandemic waves. We performed time series analysis using autoregressive integrated moving average (ARIMA) models to estimate whether Cq data information improves short-term predictions of epidemiological dynamics. RESULTS: Although we found that the Cq values varied depending on the testing laboratory or the assay used, we detected strong significant trends associated with patient age, number of days after symptoms onset or the state of the epidemic (the temporal reproduction number) at the time of the test. Furthermore, knowing the quartiles of the Cq distribution greatly reduced the error in predicting the temporal reproduction number of the COVID-19 epidemic. CONCLUSION: Our results suggest that Cq values of screening tests performed in the general population generate testable hypotheses and help improve short-term predictions for epidemic surveillance. |
format | Online Article Text |
id | pubmed-8832522 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | European Centre for Disease Prevention and Control (ECDC) |
record_format | MEDLINE/PubMed |
spelling | pubmed-88325222022-03-02 Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020 Alizon, Samuel Selinger, Christian Sofonea, Mircea T Haim-Boukobza, Stéphanie Giannoli, Jean-Marc Ninove, Laetitia Pillet, Sylvie Thibault, Vincent de Rougemont, Alexis Tumiotto, Camille Solis, Morgane Stephan, Robin Bressollette-Bodin, Céline Salmona, Maud L’Honneur, Anne-Sophie Behillil, Sylvie Lefeuvre, Caroline Dina, Julia Hantz, Sébastien Hartard, Cédric Veyer, David Delagrèverie, Héloïse M Fourati, Slim Visseaux, Benoît Henquell, Cécile Lina, Bruno Foulongne, Vincent Burrel, Sonia Euro Surveill Research BACKGROUND: The COVID-19 pandemic has led to an unprecedented daily use of RT-PCR tests. These tests are interpreted qualitatively for diagnosis, and the relevance of the test result intensity, i.e. the number of quantification cycles (Cq), is debated because of strong potential biases. AIM: We explored the possibility to use Cq values from SARS-CoV-2 screening tests to better understand the spread of an epidemic and to better understand the biology of the infection. METHODS: We used linear regression models to analyse a large database of 793,479 Cq values from tests performed on more than 2 million samples between 21 January and 30 November 2020, i.e. the first two pandemic waves. We performed time series analysis using autoregressive integrated moving average (ARIMA) models to estimate whether Cq data information improves short-term predictions of epidemiological dynamics. RESULTS: Although we found that the Cq values varied depending on the testing laboratory or the assay used, we detected strong significant trends associated with patient age, number of days after symptoms onset or the state of the epidemic (the temporal reproduction number) at the time of the test. Furthermore, knowing the quartiles of the Cq distribution greatly reduced the error in predicting the temporal reproduction number of the COVID-19 epidemic. CONCLUSION: Our results suggest that Cq values of screening tests performed in the general population generate testable hypotheses and help improve short-term predictions for epidemic surveillance. European Centre for Disease Prevention and Control (ECDC) 2022-02-10 /pmc/articles/PMC8832522/ /pubmed/35144725 http://dx.doi.org/10.2807/1560-7917.ES.2022.27.6.2100406 Text en This article is copyright of the authors or their affiliated institutions, 2022. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made. |
spellingShingle | Research Alizon, Samuel Selinger, Christian Sofonea, Mircea T Haim-Boukobza, Stéphanie Giannoli, Jean-Marc Ninove, Laetitia Pillet, Sylvie Thibault, Vincent de Rougemont, Alexis Tumiotto, Camille Solis, Morgane Stephan, Robin Bressollette-Bodin, Céline Salmona, Maud L’Honneur, Anne-Sophie Behillil, Sylvie Lefeuvre, Caroline Dina, Julia Hantz, Sébastien Hartard, Cédric Veyer, David Delagrèverie, Héloïse M Fourati, Slim Visseaux, Benoît Henquell, Cécile Lina, Bruno Foulongne, Vincent Burrel, Sonia Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020 |
title | Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020 |
title_full | Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020 |
title_fullStr | Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020 |
title_full_unstemmed | Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020 |
title_short | Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020 |
title_sort | epidemiological and clinical insights from sars-cov-2 rt-pcr crossing threshold values, france, january to november 2020 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832522/ https://www.ncbi.nlm.nih.gov/pubmed/35144725 http://dx.doi.org/10.2807/1560-7917.ES.2022.27.6.2100406 |
work_keys_str_mv | AT alizonsamuel epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT selingerchristian epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT sofoneamirceat epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT haimboukobzastephanie epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT giannolijeanmarc epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT ninovelaetitia epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT pilletsylvie epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT thibaultvincent epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT derougemontalexis epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT tumiottocamille epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT solismorgane epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT stephanrobin epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT bressollettebodinceline epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT salmonamaud epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT lhonneurannesophie epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT behillilsylvie epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT lefeuvrecaroline epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT dinajulia epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT hantzsebastien epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT hartardcedric epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT veyerdavid epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT delagreverieheloisem epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT fouratislim epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT visseauxbenoit epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT henquellcecile epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT linabruno epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT foulongnevincent epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT burrelsonia epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 AT epidemiologicalandclinicalinsightsfromsarscov2rtpcrcrossingthresholdvaluesfrancejanuarytonovember2020 |